{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:10:33Z","timestamp":1759191033842,"version":"3.44.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the foundation project of the Endemic Disease (Thalassemia) Clinical Medical Research Center of Jiangxi Province, China","award":["20223BCG74003"],"award-info":[{"award-number":["20223BCG74003"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82460040"],"award-info":[{"award-number":["82460040"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03347-9","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T12:15:31Z","timestamp":1759148131000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DNMT3A-R882 mutation promotes acute myeloid leukemia progression by recruiting E2H2 to inhibit circKCNQ5 methylation"],"prefix":"10.1007","volume":"16","author":[{"given":"Yijian","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengxiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liuyan","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"3347_CR1","doi-asserted-by":"publisher","first-page":"n2026","DOI":"10.1136\/bmj.n2026","volume":"375","author":"LF Newell","year":"2021","unstructured":"Newell LF, Cook RJ. Advances in acute myeloid leukemia. BMJ. 2021;375:n2026.","journal-title":"BMJ"},{"key":"3347_CR2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","volume":"36","author":"RM Shallis","year":"2019","unstructured":"Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM. Epidemiology of acute myeloid leukemia: recent progress and enduring challenges. Blood Rev. 2019;36:70\u201387.","journal-title":"Blood Rev"},{"key":"3347_CR3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11864-014-0281-9","volume":"15","author":"PH Wiernik","year":"2014","unstructured":"Wiernik PH. Optimal therapy for adult patients with acute myeloid leukemia in first complete remission. Curr Treat Options Oncol. 2014;15:171\u201386.","journal-title":"Curr Treat Options Oncol"},{"key":"3347_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11864-017-0456-2","volume":"18","author":"P Bose","year":"2017","unstructured":"Bose P, Vachhani P, Cortes JE. Treatment of relapsed\/refractory acute myeloid leukemia. Curr Treat Options Oncol. 2017;18:17.","journal-title":"Curr Treat Options Oncol"},{"key":"3347_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13045-017-0543-7","volume":"11","author":"X Yang","year":"2018","unstructured":"Yang X, Wang J. Precision therapy for acute myeloid leukemia. J Hematol Oncol. 2018;11:3.","journal-title":"J Hematol Oncol"},{"key":"3347_CR6","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/gcc.22805","volume":"58","author":"M Chopra","year":"2019","unstructured":"Chopra M, Bohlander SK. The cell of origin and the leukemia stem cell in acute myeloid leukemia. Genes Chromosomes Cancer. 2019;58:850\u20138.","journal-title":"Genes Chromosomes Cancer"},{"key":"3347_CR7","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1038\/s41375-021-01338-7","volume":"35","author":"LC Stetson","year":"2021","unstructured":"Stetson LC, Balasubramanian D, Ribeiro SP, Stefan T, Gupta K, Xu X, Fourati S, Roe A, Jackson Z, Schauner R, et al. Single cell RNA sequencing of AML initiating cells reveals RNA-based evolution during disease progression. Leukemia. 2021;35:2799\u2013812.","journal-title":"Leukemia"},{"key":"3347_CR8","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/gcc.22806","volume":"58","author":"S Vosberg","year":"2019","unstructured":"Vosberg S, Greif PA. Clonal evolution of acute myeloid leukemia from diagnosis to relapse. Genes Chromosomes Cancer. 2019;58:839\u201349.","journal-title":"Genes Chromosomes Cancer"},{"key":"3347_CR9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41568-019-0230-9","volume":"20","author":"D Vetrie","year":"2020","unstructured":"Vetrie D, Helgason GV, Copland M. The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML. Nat Rev Cancer. 2020;20:158\u201373.","journal-title":"Nat Rev Cancer"},{"key":"3347_CR10","doi-asserted-by":"publisher","first-page":"16010","DOI":"10.1038\/nrdp.2016.10","volume":"2","author":"A Khwaja","year":"2016","unstructured":"Khwaja A, Bjorkholm M, Gale RE, Levine RL, Jordan CT, Ehninger G, Bloomfield CD, Estey E, Burnett A, Cornelissen JJ, et al. Acute myeloid leukaemia. Nat Rev Dis Primers. 2016;2:16010.","journal-title":"Nat Rev Dis Primers"},{"key":"3347_CR11","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3390\/genes11080868","volume":"11","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Su Y, Wang S, Liu Y, Jin L, Wan Q, Liu Y, Li C, Sang X, Yang L, et al. Identification of circRNA-lncRNA-miRNA-mRNA competitive endogenous RNA network as novel prognostic markers for acute myeloid leukemia. Genes (Basel). 2020;11:868.","journal-title":"Genes (Basel)"},{"key":"3347_CR12","doi-asserted-by":"publisher","first-page":"15288","DOI":"10.1002\/jcb.28796","volume":"120","author":"N El-Khazragy","year":"2019","unstructured":"El-Khazragy N, Ghozy S, Matbouly S, Zaki W, Safwat G, Hussien G, Khalifa O. Interaction between 12p chromosomal abnormalities and Lnc-HOTAIR mediated pathway in acute myeloid leukemia. J Cell Biochem. 2019;120:15288\u201396.","journal-title":"J Cell Biochem"},{"key":"3347_CR13","doi-asserted-by":"publisher","first-page":"106727","DOI":"10.1016\/j.leukres.2021.106727","volume":"111","author":"D Padmakumar","year":"2021","unstructured":"Padmakumar D, Chandraprabha VR, Gopinath P, Vimala Devi ART, Anitha GRJ, Sreelatha MM, Padmakumar A, Sreedharan H. A concise review on the molecular genetics of acute myeloid leukemia. Leuk Res. 2021;111:106727.","journal-title":"Leuk Res"},{"key":"3347_CR14","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nature25477","volume":"554","author":"ZM Zhang","year":"2018","unstructured":"Zhang ZM, Lu R, Wang P, Yu Y, Chen D, Gao L, Liu S, Ji D, Rothbart SB, Wang Y, et al. Structural basis for DNMT3A-mediated de novo DNA methylation. Nature. 2018;554:387\u201391.","journal-title":"Nature"},{"key":"3347_CR15","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12967-019-1959-3","volume":"17","author":"XQ Yuan","year":"2019","unstructured":"Yuan XQ, Chen P, Du YX, Zhu KW, Zhang DY, Yan H, Liu H, Liu YL, Cao S, Zhou G, et al. Influence of DNMT3A R882 mutations on AML prognosis determined by the allele ratio in Chinese patients. J Transl Med. 2019;17:220.","journal-title":"J Transl Med"},{"key":"3347_CR16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nsmb.2959","volume":"22","author":"Z Li","year":"2015","unstructured":"Li Z, Huang C, Bao C, Chen L, Lin M, Wang X, Zhong G, Yu B, Hu W, Dai L, et al. Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015;22:256\u201364.","journal-title":"Nat Struct Mol Biol"},{"key":"3347_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12943-021-01446-z","volume":"20","author":"V Singh","year":"2021","unstructured":"Singh V, Uddin MH, Zonder JA, Azmi AS, Balasubramanian SK. Circular rnas in acute myeloid leukemia. Mol Cancer. 2021;20:149.","journal-title":"Mol Cancer"},{"key":"3347_CR18","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/hon.2874","volume":"39","author":"D Wang","year":"2021","unstructured":"Wang D, Ming X, Xu J, Xiao Y. Circ_0009910 shuttled by exosomes regulates proliferation, cell cycle and apoptosis of acute myeloid leukemia cells by regulating miR-5195-3p\/GRB10 axis. Hematol Oncol. 2021;39:390\u2013400.","journal-title":"Hematol Oncol"},{"key":"3347_CR19","doi-asserted-by":"publisher","first-page":"7704","DOI":"10.1080\/21655979.2021.1982310","volume":"12","author":"W Liu","year":"2021","unstructured":"Liu W, Cheng F. Circular RNA circcrkl inhibits the proliferation of acute myeloid leukemia cells via the miR-196a-5p\/miR-196b-5p\/p27 axis. Bioengineered. 2021;12:7704\u201313.","journal-title":"Bioengineered"},{"key":"3347_CR20","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.18632\/aging.202240","volume":"13","author":"Q Hu","year":"2020","unstructured":"Hu Q, Gu Y, Chen S, Tian Y, Yang S. Hsa_circ_0079480 promotes tumor progression in acute myeloid leukemia via miR-654-3p\/HDGF axis. Aging. 2020;13:1120\u201331.","journal-title":"Aging"},{"key":"3347_CR21","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.2147\/CMAR.S281690","volume":"13","author":"H Li","year":"2021","unstructured":"Li H, Bi K, Feng S, Wang Y, Zhu C. CircRNA circ_POLA2 is upregulated in acute myeloid leukemia (AML) and promotes cell proliferation by suppressing the production of mature miR-34a. Cancer Manag Res. 2021;13:3629\u201337.","journal-title":"Cancer Manag Res"},{"key":"3347_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12885-020-6515-2","volume":"20","author":"F Zhou","year":"2020","unstructured":"Zhou F, Wang D, Wei W, Chen H, Shi H, Zhou N, Wu L, Peng R. Comprehensive profiling of circular RNA expressions reveals potential diagnostic and prognostic biomarkers in multiple myeloma. BMC Cancer. 2020;20:40.","journal-title":"BMC Cancer"},{"key":"3347_CR23","first-page":"525","volume":"38","author":"Y Li","year":"2022","unstructured":"Li Y, Wang L, Zhang N, Xu Y. CircKCNQ5 controls proliferation, migration, invasion, apoptosis, and Glycolysis of multiple myeloma cells by modulating miR-335-5p\/BRD4 axis. Histol Histopathol. 2022;38:525.","journal-title":"Histol Histopathol."},{"key":"3347_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3892\/ijo.2021.5287","volume":"59","author":"MA Issah","year":"2021","unstructured":"Issah MA, Wu D, Zhang F, Zheng W, Liu Y, Fu H, Zhou H, Chen R, Shen J. Epigenetic modifications in acute myeloid leukemia: the emerging role of circular RNAs (Review). Int J Oncol. 2021;59:107.","journal-title":"Int J Oncol"},{"key":"3347_CR25","doi-asserted-by":"publisher","first-page":"107627","DOI":"10.1016\/j.envint.2022.107627","volume":"170","author":"M Qiu","year":"2022","unstructured":"Qiu M, Zhang N, Yao S, Zhou H, Chen X, Jia Y, Zhang H, Li X, Jiang Y. DNMT3A-mediated high expression of circ_0057504 promotes benzo[a]pyrene-induced DNA damage via the NONO-SFPQ complex in human bronchial epithelial cells. Environ Int. 2022;170:107627.","journal-title":"Environ Int"},{"key":"3347_CR26","doi-asserted-by":"publisher","first-page":"2478309","DOI":"10.1080\/07853890.2025.2478309","volume":"57","author":"Y Chen","year":"2025","unstructured":"Chen Y, Zhu X, Lin C, Xu R, Xu P, Xin L, Li L, Zhang L. circKCNQ5 promotes the proliferation of DNA-methyltransferase 3A R882 mutated acute myeloid leukemia cells by elevating high-mobility group box 1 expression. Ann Med. 2025;57:2478309.","journal-title":"Ann Med"},{"key":"3347_CR27","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12964-022-00978-1","volume":"20","author":"X Chu","year":"2022","unstructured":"Chu X, Zhong L, Dan W, Wang X, Zhang Z, Liu Z, Lu Y, Shao X, Zhou Z, Chen S, et al. DNMT3A R882H mutation drives daunorubicin resistance in acute myeloid leukemia via regulating NRF2\/NQO1 pathway. Cell Commun Signal. 2022;20:168.","journal-title":"Cell Commun Signal"},{"key":"3347_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41392-022-00902-6","volume":"7","author":"Y Li","year":"2022","unstructured":"Li Y, Gan Y, Liu J, Li J, Zhou Z, Tian R, Sun R, Liu J, Xiao Q, Li Y, et al. Downregulation of MEIS1 mediated by ELFN1-AS1\/EZH2\/DNMT3a axis promotes tumorigenesis and oxaliplatin resistance in colorectal cancer. Signal Transduct Target Ther. 2022;7:87.","journal-title":"Signal Transduct Target Ther"},{"key":"3347_CR29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13148-024-01685-z","volume":"16","author":"X Hu","year":"2024","unstructured":"Hu X, Ye Q, Lu H, Wu Z, Chen S, Zheng R. Estrogen-mediated DNMT1 and DNMT3A recruitment by EZH2 silences miR-570-3p that contributes to papillary thyroid malignancy through DPP4. Clin Epigenetics. 2024;16:81.","journal-title":"Clin Epigenetics"},{"key":"3347_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0352-x","volume":"51","author":"W Jang","year":"2019","unstructured":"Jang W, Park J, Kwon A, Choi H, Kim J, Lee GD, Han E, Jekarl DW, Chae H, Han K, et al. CDKN2B downregulation and other genetic characteristics in T-acute lymphoblastic leukemia. Exp Mol Med. 2019;51:1\u201315.","journal-title":"Exp Mol Med"},{"key":"3347_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5045\/br.2020.55.1.17","volume":"55","author":"DJ Park","year":"2020","unstructured":"Park DJ, Kwon A, Cho BS, Kim HJ, Hwang KA, Kim M, Kim Y. Characteristics of DNMT3A mutations in acute myeloid leukemia. Blood Res. 2020;55:17\u201326.","journal-title":"Blood Res"},{"key":"3347_CR32","doi-asserted-by":"publisher","first-page":"16966","DOI":"10.1074\/jbc.RA119.010126","volume":"294","author":"TV Nguyen","year":"2019","unstructured":"Nguyen TV, Yao S, Wang Y, Rolfe A, Selvaraj A, Darman R, Ke J, Warmuth M, Smith PG, Larsen NA, et al. The R882H DNMT3A hot spot mutation stabilizes the formation of large DNMT3A oligomers with low DNA methyltransferase activity. J Biol Chem. 2019;294:16966\u201377.","journal-title":"J Biol Chem"},{"key":"3347_CR33","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.neo.2018.08.013","volume":"20","author":"R Bera","year":"2018","unstructured":"Bera R, Chiu MC, Huang YJ, Liang DC, Lee YS, Shih LY. Genetic and epigenetic perturbations by DNMT3A-R882 mutants impaired apoptosis through augmentation of PRDX2 in myeloid leukemia cells. Neoplasia. 2018;20:1106\u201320.","journal-title":"Neoplasia"},{"key":"3347_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/gm551","volume":"6","author":"M Sonnet","year":"2014","unstructured":"Sonnet M, Claus R, Becker N, Zucknick M, Petersen J, Lipka DB, Oakes CC, Andrulis M, Lier A, Milsom MD, et al. Early aberrant DNA methylation events in a mouse model of acute myeloid leukemia. Genome Med. 2014;6:34.","journal-title":"Genome Med"},{"key":"3347_CR35","doi-asserted-by":"publisher","first-page":"e613","DOI":"10.1038\/bcj.2017.86","volume":"7","author":"CK Lai","year":"2017","unstructured":"Lai CK, Norddahl GL, Maetzig T, Rosten P, Lohr T, Sanchez Milde L, von Krosigk N, Docking TR, Heuser M, Karsan A, et al. Meis2 as a critical player in MN1-induced leukemia. Blood Cancer J. 2017;7:e613.","journal-title":"Blood Cancer J"},{"key":"3347_CR36","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/bjh.19508","volume":"205","author":"MWM K\u00fchn","year":"2024","unstructured":"K\u00fchn MWM, Ganser A. The Menin story in acute myeloid leukaemia-The road to success. Br J Haematol. 2024;205:812\u20134.","journal-title":"Br J Haematol"},{"key":"3347_CR37","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.3324\/haematol.2012.079012","volume":"98","author":"GJ Dickson","year":"2013","unstructured":"Dickson GJ, Liberante FG, Kettyle LM, O\u2019Hagan KA, Finnegan DP, Bullinger L, Geerts D, McMullin MF, Lappin TR, Mills KI, et al. HOXA\/PBX3 knockdown impairs growth and sensitizes cytogenetically normal acute myeloid leukemia cells to chemotherapy. Haematologica. 2013;98:1216\u201325.","journal-title":"Haematologica"},{"key":"3347_CR38","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1158\/0008-5472.CAN-15-1566","volume":"76","author":"Z Li","year":"2016","unstructured":"Li Z, Chen P, Su R, Hu C, Li Y, Elkahloun AG, Zuo Z, Gurbuxani S, Arnovitz S, Weng H, et al. PBX3 and MEIS1 cooperate in hematopoietic cells to drive acute myeloid leukemias characterized by a core transcriptome of the MLL-Rearranged disease. Cancer Res. 2016;76:619\u201329.","journal-title":"Cancer Res"},{"key":"3347_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12185-016-2124-x","volume":"105","author":"G Sashida","year":"2017","unstructured":"Sashida G, Iwama A. Multifaceted role of the polycomb-group gene EZH2 in hematological malignancies. Int J Hematol. 2017;105:23\u201330.","journal-title":"Int J Hematol"},{"key":"3347_CR40","doi-asserted-by":"crossref","unstructured":"Rinke J, Chase A, Cross NCP, Hochhaus A, Ernst T. (2020) EZH2 in Myeloid Malignancies. Cells 9.","DOI":"10.3390\/cells9071639"},{"key":"3347_CR41","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nature04431","volume":"439","author":"E Vir\u00e9","year":"2006","unstructured":"Vir\u00e9 E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C, Morey L, Van Eynde A, Bernard D, Vanderwinden JM, et al. The polycomb group protein EZH2 directly controls DNA methylation. Nature. 2006;439:871\u20134.","journal-title":"Nature"},{"key":"3347_CR42","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1101\/gad.186411.111","volume":"26","author":"C Simon","year":"2012","unstructured":"Simon C, Chagraoui J, Krosl J, Gendron P, Wilhelm B, Lemieux S, Boucher G, Chagnon P, Drouin S, Lambert R, et al. A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia. Genes Dev. 2012;26:651\u20136.","journal-title":"Genes Dev"},{"key":"3347_CR43","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.advms.2019.07.002","volume":"64","author":"A Mechaal","year":"2019","unstructured":"Mechaal A, Menif S, Abbes S, Safra I. EZH2, new diagnosis and prognosis marker in acute myeloid leukemia patients. Adv Med Sci. 2019;64:395\u2013401.","journal-title":"Adv Med Sci"},{"key":"3347_CR44","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3390\/biom11060781","volume":"11","author":"Y Yang","year":"2021","unstructured":"Yang Y, Dai Y, Yang X, Wu S, Wang Y. DNMT3A mutation-induced CDK1 overexpression promotes leukemogenesis by modulating the interaction between EZH2 and DNMT3A. Biomolecules. 2021;11:781.","journal-title":"Biomolecules"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03347-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03347-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03347-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T13:03:20Z","timestamp":1759151000000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03347-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3347"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03347-9","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments were approved by the Institutional Animal Care and Use Committee of Gannan Medical University in compliance with the guidelines outlined in the Declaration of Helsinki and the Basel Declaration (2024158; 3 Apr. 2024).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1746"}}